Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingye Wu

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Annals of Palliative Medicine|May 10, 2021
Ripretinib in treatment of repeatedly relapsing rectal gastrointestinal stromal tumor: a case reportChao Wu, Jun Zhang, Xingye Wu
Pathology Oncology Research : POR|August 10, 2018
High Expression of PhospholipaseD2 Induced by Hypoxia Promotes Proliferation of Colon Cancer Cells through Activating NF- κ Bp65 Signaling PathwayMaoxi Liu, Kunli Du, Bo Jiang, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 25, 2016
[Long-term survival of total laparoscopic radical distal gastrectomy with delta-shaped anastomosis]Rui Luo, Yinggang Ge, Xingye Wu, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 5, 2011
Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNAXuehu Wang, Zhongxue Fu, Yu Zhao, et al.
Medical Oncology (Northwood, London, England)|November 30, 2014
Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditionsMaoxi Liu, Kunli Du, Zhongxue Fu, et al.
Frontiers in Surgery|March 13, 2023
Changes in imatinib plasma trough level during long-term treatment in patients with intermediate- or high-risk gastrointestinal stromal tumors: Relationship between covariates and imatinib plasma trough levelXingye Wu, Yinggang Ge, Xuemei He, et al.
Plos One|May 14, 2024
A case-matched study of imatinib mesylate between different formulations on plasma trough concentration, adverse events, quality of life and outcomes in gastrointestinal stromal tumor patientsLi Zeng, Xiang Cheng, Juan Li, et al.
Patient Preference and Adherence|August 22, 2022
Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to GenderPan Ran, Juan Li, Xingye Wu, et al.
The Journal of Biological Chemistry|February 28, 2012
Clinicopathological and biological significance of human voltage-gated proton channel Hv1 protein overexpression in breast cancerYifan Wang, Shu Jie Li, Xingye Wu, et al.
Plos One|August 14, 2013
Human voltage-gated proton channel hv1: a new potential biomarker for diagnosis and prognosis of colorectal cancerYifan Wang, Xingye Wu, Qiang Li, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Annals of Palliative Medicine|May 10, 2021
Ripretinib in treatment of repeatedly relapsing rectal gastrointestinal stromal tumor: a case reportChao Wu, Jun Zhang, Xingye Wu
Pathology Oncology Research : POR|August 10, 2018
High Expression of PhospholipaseD2 Induced by Hypoxia Promotes Proliferation of Colon Cancer Cells through Activating NF- κ Bp65 Signaling PathwayMaoxi Liu, Kunli Du, Bo Jiang, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 25, 2016
[Long-term survival of total laparoscopic radical distal gastrectomy with delta-shaped anastomosis]Rui Luo, Yinggang Ge, Xingye Wu, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 5, 2011
Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNAXuehu Wang, Zhongxue Fu, Yu Zhao, et al.
Medical Oncology (Northwood, London, England)|November 30, 2014
Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditionsMaoxi Liu, Kunli Du, Zhongxue Fu, et al.
Frontiers in Surgery|March 13, 2023
Changes in imatinib plasma trough level during long-term treatment in patients with intermediate- or high-risk gastrointestinal stromal tumors: Relationship between covariates and imatinib plasma trough levelXingye Wu, Yinggang Ge, Xuemei He, et al.
Plos One|May 14, 2024
A case-matched study of imatinib mesylate between different formulations on plasma trough concentration, adverse events, quality of life and outcomes in gastrointestinal stromal tumor patientsLi Zeng, Xiang Cheng, Juan Li, et al.
Patient Preference and Adherence|August 22, 2022
Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to GenderPan Ran, Juan Li, Xingye Wu, et al.
The Journal of Biological Chemistry|February 28, 2012
Clinicopathological and biological significance of human voltage-gated proton channel Hv1 protein overexpression in breast cancerYifan Wang, Shu Jie Li, Xingye Wu, et al.
Plos One|August 14, 2013
Human voltage-gated proton channel hv1: a new potential biomarker for diagnosis and prognosis of colorectal cancerYifan Wang, Xingye Wu, Qiang Li, et al.
Pageof 8